IRIDEX (NASDAQ:IRIX) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of IRIDEX (NASDAQ:IRIX) in a research report report published on Monday. The firm issued a hold rating on the medical equipment provider’s stock.

IRIDEX Stock Down 20.8 %

Shares of NASDAQ:IRIX opened at $0.80 on Monday. The company has a market capitalization of $13.31 million, a P/E ratio of -1.19 and a beta of 0.94. The stock’s fifty day simple moving average is $1.49 and its 200-day simple moving average is $1.64. IRIDEX has a 52-week low of $0.78 and a 52-week high of $3.65. The company has a quick ratio of 0.85, a current ratio of 1.54 and a debt-to-equity ratio of 0.55.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.